Nautilus Biotechnolgy, Inc. (NAUT)
NASDAQ·Healthcare·Biotechnology
$1.03
+3.58%
Mkt Cap $118.08M
Analyst Ratings
No recent rating data.
Price Target (2 analysts)
$2.50
Range $2.50 – $2.50
Implied Upside
+143.9%
Consensus $2.50 vs current $1.03
NASDAQ·Healthcare·Biotechnology
$1.03
+3.58%
Mkt Cap $118.08M
No recent rating data.
Price Target (2 analysts)
$2.50
Range $2.50 – $2.50
+143.9%
Consensus $2.50 vs current $1.03